Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Antioxidants (Basel, Switzerland)|February 25, 2023
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular TherapeuticsEva Ramos, Emilio Gil-Martín, Cristóbal De Los Ríos, et al.
Journal of Medicinal Chemistry|June 26, 2010
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivativesCristóbal de Los Ríos, Javier Egea, José Marco-Contelles, et al.
Journal of Neuroscience Research|June 15, 2011
Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibitionSimone Molz, Tharine Dal-Cim, Josiane Budni, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 14, 2025
Unveiling the interplay between soluble guanylate cyclase activation and redox signalling in stroke pathophysiology and treatmentAlexander G Grønning, Sebastian E Vonhof, Mahmoud Elbatreek, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and AgingVictoria Jiménez Carretero, Eva Ramos, Pedro Segura-Chama, et al.
Journal of Neurochemistry|February 18, 2009
The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulationEmma Burgos-Ramos, Gabriel A Martos-Moreno, Manuela G López, et al.
ACS Chemical Neuroscience|July 11, 2014
ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's diseaseAlejandro Romero, Javier Egea, Gema C González-Muñoz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damageAna I Casas, Eva Geuss, Pamela W M Kleikers, et al.
British Journal of Pharmacology|November 13, 2021
Time-dependent dual effect of NLRP3 inflammasome in brain ischaemiaAlejandra Palomino-Antolin, Paloma Narros-Fernández, Víctor Farré-Alins, et al.
European Journal of Pharmacology|January 18, 2021
Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's diseaseJosé María Sánchez Montero, Angel Agis-Torres, David Solano, et al.
Pageof 13